Table 1 Summary of patient clinical and pathologic information
|  | Normal (n = 3) | All Tumors (n = 12) | SETD2 wt (n = 6) | SETD2 mt (n = 6) | p value (wt v mt) |
|---|---|---|---|---|---|
Age (years) | 71.67 ± 5.03 | 63.58 ± 7.76 | 61.00 ± 7.85 | 66.17 ± 7.41 |  |
p = 0.081 | p = 0.378* |  | |||
Sex (males) | 2 (66.67%) | 9 (75%) | 4 (66.67%) | 5 (83.33%) | Â |
p = 0.661 | p = 0.999 |  | |||
SSIGN Score (4–8/ ≥ 9) |  | 9/3 | 5/1 | 4/2 | 0.999 |
T-Stage (T1/T2/T3/T4) | Â | 4/0/8/0 | 2/0/4/0 | 2/0/4/0 | 1.000 |
Tumor Size (cm) |  | 8.33 ± 4.08 | 9.20 ± 2.86 | 9.00 ± 4.88 | 0.933 |
Grade (2/3/4) | Â | 6/4/2 | 3/2/1 | 3/2/1 | 1.000 |
Necrosis (yes) | Â | 3 (25%) | 1 (16.67%) | 2 (33.33%) | 0.999 |
Nodal Stage | Â | N0 | N0 | N0 | Â |
M Stage (M1) | Â | 7 (58.33%) | 3 (50%) | 4 (66.67%) | 0.999 |